The use of nedocromil sodium 4 mg q.i.d. in asthmatics with mildly unstable asthma induced by a reduction of their inhaled beclomethasone dipropionate dose was investigated in a double-blind, parallel group, placebo-controlled study. Compared with placebo, nedocromil sodium improved night-time and daytime asthma score, night-time and daytime bronchodilator use, and evening PEFR at some stage during the 4-week treatment. It is concluded that nedocromil sodium exerts a beneficial effect in chronic asthma.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Regulation of reactive oxygen species and the role of mitochondrial apoptotic-related genes in rheumatoid arthritis.
Sci Rep
January 2025
Department of Rheumatology and Immunology, Shanxi Provincial People's Hospital, Taiyuan, 030012, China.
Previous research suggests mitochondrial apoptosis alleviates rheumatoid arthritis (RA), but the role of mitochondrial apoptosis-related genes (MARGs) is unclear. Urgent exploration of RA-related mitochondrial apoptosis biomarkers is needed. Gene Expression Ontology (GEO)-derived RA datasets were used to identify differentially expressed genes (DEGs) compared to normal controls, intersected with MARGs to obtain differentially expressed mitochondrial apoptosis-related genes (DE-MARGs).
View Article and Find Full Text PDFIdentification of Potential Tryptase Inhibitors from FDA-Approved Drugs Using Machine Learning, Molecular Docking, and Experimental Validation.
ACS Omega
September 2024
Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon, 24341, Republic of Korea.
Article Synopsis
- * The selected compounds underwent molecular docking to evaluate their binding to tryptase and were experimentally tested in rat basophilic leukemia cells to measure their efficacy in inhibiting tryptase and related activities.
- * Results indicated that certain FDA-approved drugs, such as landiolol and cidofovir, effectively inhibited tryptase, showcasing machine learning's potential in drug repurposing and aiding the development of treatments for related diseases.
Exploration of key drug target proteins highlighting their related regulatory molecules, functional pathways and drug candidates associated with delirium: evidence from meta-data analyses.
BMC Geriatr
November 2023
NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2006, Australia.
Background: Delirium is a prevalent neuropsychiatric medical phenomenon that causes serious emergency outcomes, including mortality and morbidity. It also increases the suffering and the economic burden for families and carers. Unfortunately, the pathophysiology of delirium is still unknown, which is a major obstacle to therapeutic development.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!